000 01331 a2200421 4500
005 20250511211802.0
264 0 _c19911011
008 199110s 0 0 eng d
022 _a0028-3878
024 7 _a10.1212/wnl.41.9.1457
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPortenoy, R K
245 0 0 _aChronic morphine therapy for cancer pain: plasma and cerebrospinal fluid morphine and morphine-6-glucuronide concentrations.
_h[electronic resource]
260 _bNeurology
_cSep 1991
300 _a1457-61 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMorphine
_xblood
650 0 4 _aMorphine Derivatives
_xblood
650 0 4 _aNeoplasms
_xblood
650 0 4 _aPain
_xdrug therapy
700 1 _aKhan, E
700 1 _aLayman, M
700 1 _aLapin, J
700 1 _aMalkin, M G
700 1 _aFoley, K M
700 1 _aThaler, H T
700 1 _aCerbone, D J
700 1 _aInturrisi, C E
773 0 _tNeurology
_gvol. 41
_gno. 9
_gp. 1457-61
856 4 0 _uhttps://doi.org/10.1212/wnl.41.9.1457
_zAvailable from publisher's website
999 _c1897299
_d1897299